10-Q: Cartesian Growth Corporation II Reports Net Income of $2.5 Million for Q1 2024 Amidst Business Combination Extension
Quarterly Report
Cartesian Growth Corporation II reported a net income of $2.5 million for the first quarter of 2024, primarily driven by changes in the fair value of warrant liabilities and interest income, while extending its business combination deadline.
Summary
- Cartesian Growth Corporation II, a blank check company, reported a net income of $2.53 million for the three months ended March 31, 2024.
- This net income is primarily attributed to a $449,330 change in the fair value of warrant liabilities, a $32,239 change in the fair value of a convertible promissory note with a related party, and $2.28 million in interest earned on cash and marketable securities held in a trust account.
- The company's operating and formation costs were $223,183 for the quarter.
- The company extended its deadline to complete a business combination to November 10, 2024, by utilizing monthly extensions, each requiring a deposit into the trust account by the sponsor.
- In connection with the extension, the company issued a $1.8 million promissory note to the sponsor and drew $900,000 from the note for the extensions through May 10, 2024.
- As of March 31, 2024, the company held $176.98 million in cash and marketable securities in its trust account and had a working capital deficit of $1.62 million.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While the company reported a net income, it is primarily due to non-operating items. The extension of the business combination deadline and the going concern warning raise concerns, but are not unusual for a SPAC. The company is still in the process of finding a target and faces risks related to its liquidity and the deadline.
Positives
- The company generated a net income of $2.53 million for the quarter.
- The trust account balance remains substantial at $176.98 million.
- The company successfully extended its business combination deadline, providing more time to find a suitable target.
Negatives
- The company has a working capital deficit of $1.62 million.
- The company has not yet completed a business combination and is relying on extensions.
- The company's operating costs were $223,183 for the quarter.
Risks
- The company's ability to continue as a going concern is in doubt due to its liquidity condition and the upcoming liquidation date if a business combination is not completed.
- The company is dependent on the sponsor for funding through promissory notes and working capital loans.
- The company's ability to complete a business combination may be affected by global economic consequences and market volatility.
- If a business combination is not completed by the deadline, the company will liquidate and shareholders may receive less than the initial $10.30 per share due to potential claims against the trust account.
Future Outlook
The company is focused on completing a business combination by the extended deadline of November 10, 2024, and may use funds from the trust account and other sources to finance the transaction. The company may also seek additional working capital loans from the sponsor or its affiliates.
Management Comments
- Management has determined that the company's liquidity condition and liquidation date raise substantial doubt about the company's ability to continue as a going concern.
- Management believes that the disclosure controls and procedures were effective at a reasonable assurance level.
Industry Context
This report is typical for a special purpose acquisition company (SPAC) that is in the process of seeking a business combination. The extension of the deadline and reliance on sponsor funding are common occurrences in the SPAC lifecycle.
Comparison to Industry Standards
- The financial results are typical for a SPAC in its pre-business combination phase, with minimal operating activity and reliance on interest income from the trust account.
- The extension of the business combination deadline is a common practice among SPACs that have not yet identified a suitable target.
- The reliance on sponsor funding through promissory notes and working capital loans is also a standard practice in the SPAC industry.
- The company's working capital deficit is not unusual for a SPAC in this stage, as it is primarily focused on identifying and completing a business combination rather than generating revenue.
Related Party Transactions
- The company has entered into several related-party transactions with its sponsor, including a monthly administrative services agreement, promissory notes, and potential working capital loans.
- The sponsor has provided a $1.8 million promissory note to fund the monthly extensions of the business combination deadline.
- The sponsor has the option to convert the promissory notes into warrants at a price of $1.00 per warrant.
Stakeholder Impact
- Shareholders face the risk of liquidation if a business combination is not completed by the deadline, potentially receiving less than the initial $10.30 per share.
- The company's employees and management are dependent on the successful completion of a business combination for their future roles.
- The company's creditors, including the underwriters, are dependent on the successful completion of a business combination for the payment of deferred fees.
Next Steps
- The company will continue to seek a suitable target for a business combination.
- The company will continue to utilize monthly extensions to extend the business combination deadline, if necessary.
- The company may seek additional working capital loans from the sponsor or its affiliates to finance transaction costs related to a business combination.
Key Dates
| Date | Description |
|---|---|
| October 13, 2021 | Cartesian Growth Corporation II was incorporated. |
| May 5, 2022 | The registration statement for the Initial Public Offering was declared effective. |
| May 10, 2022 | The company consummated its Initial Public Offering. |
| November 6, 2023 | Shareholders approved an amendment to extend the business combination deadline. |
| November 10, 2023 | Original deadline for the business combination. |
| December 6, 2023 | First one-month extension of the business combination deadline. |
| January 8, 2024 | Second one-month extension of the business combination deadline. |
| January 19, 2024 | The company issued a $250,000 unsecured promissory note to the sponsor. |
| February 5, 2024 | Third one-month extension of the business combination deadline. |
| March 5, 2024 | Fourth one-month extension of the business combination deadline. |
| March 31, 2024 | End of the reporting period for the quarterly report. |
| April 9, 2024 | Fifth one-month extension of the business combination deadline. |
| May 6, 2024 | Sixth one-month extension of the business combination deadline. |
| May 10, 2024 | Sixth one-month extension of the business combination deadline. |
| May 14, 2024 | Date of the quarterly report filing. |
| June 10, 2024 | Seventh one-month extension of the business combination deadline. |
| November 10, 2024 | Extended deadline for the business combination. |
Keywords
business combination, SPAC, special purpose acquisition company, trust account, warrant liabilities, promissory note, extension, net income, liquidation, redemption
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.